ANI

Novel monoclonal antibody therapy cuts LDL cholesterol by half in high-risk patient populationWashington [US], November 16 (ANI): The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol–the so-called “bad” cholesterol–by...